Clinical trialNCT03769922UnknownInterventional

Postoperative Progression of the Disease Following Extensive Versus Limited Mesenteric Excision for Crohn's Disease

SponsorJinling Hospital, ChinaEnrollment116Postoperative Surgical Recurrence

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study evaluates whether there is a reduction in the rate of postoperative progression of the disease following extensive mesenteric excision (EME), when compared to that of limited mesenteric excision (LME), in patients undergoing ileocolic resection for Crohn's disease. Half of participants will receive EME, while the other half will receive LME.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John Calvin Coffey
University Hospital Limerick, Limerick, Ireland.
Principal Investigator
clinicaltrials.gov ↗
Luca Stocchi
The Cleveland Clinic
Principal Investigator
clinicaltrials.gov ↗
Zhu Weiming
Jinling Hospital, Nanjing, China.
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China

General Hospital of Eastern Theater Command
Nanjing, Jiangsu, China
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 18 Feb 2019
Primary completion: 31 Jan 2024
Completion: 31 Jan 2025
Last update posted: 27 Feb 2019
Registered enrollment: 116
Registry id: NCT03769922

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.